Model Details

Patient Information for Model: BCM-PDAC-18

Patient Information
Clinical Timeline


Clinical Information at Collection
Clinical Biomarkers/Mutations at Collection
Pathology Information at Collection

Model Information for Model: BCM-PDAC-18

Model Details
Mutations
There are no omics data for this model.

CNV


Metastasis Information for Model: BCM-PDAC-18
 
Patient
PDX
Liver
Local recurrence
Lung
Rectum
lymph node

Patient Treatment Information for Model: BCM-PDAC-18

Event IdTreatmentTreatment SettingAge at StartAge at EndDurationClinical ResponsePathologic ResponseReason Stopped
15Gemcitabine/AbraxaneNeoadjuvant65.0665.251 daysStable Disease (SD); "NO" progression of disease No Response (NR)Completed regimen
25Gemcitabine Adjuvant65.7566.15146 daysStable Disease (SD); Rising CA19-9Completed regimen
30CapecitabineAdjuvant67.1667.64175 daysStable Disease (SD)Completed regimen
40Gemcitabine/AbraxaneAdjuvant68.2668.4984 daysProgressive Disease (PD)Patient transferred to other hospital












Timeout
Your session is about to expire. Click 'Stay Connected' to continue the session.